Related Experiment Video
Updated: Jun 23, 2026
07:54
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
19.7K
Exploring the Impact of Obstructive Sleep Apnea on Cirrhosis: A Comprehensive Review
Zahra Dossaji1, Rajan Amin2, Vignan Manne2
1Department of Internal Medicine.
Journal of Clinical Gastroenterology
|March 19, 2025
Summary
Obstructive sleep apnea (OSA) is linked to a higher risk of cirrhosis. Continuous positive airway pressure (CPAP) may slow liver disease progression, highlighting the need for OSA screening in liver patients.
Area of Science:
- Hepatology
- Sleep Medicine
- Internal Medicine
Background:
- Obstructive sleep apnea (OSA) is well-documented to impact metabolic dysfunction-associated steatotic liver disease (MASLD).
- Limited research exists on the association between OSA and other forms of chronic liver disease, particularly cirrhosis.
- Undiagnosed OSA may accelerate the progression of existing liver conditions.
Purpose of the Study:
- To review existing literature on the relationship between obstructive sleep apnea (OSA) and cirrhosis.
- To explore OSA's potential role in the progression of liver disease.
- To identify the need for screening and management of sleep disturbances in patients with liver disease.
Main Methods:
- Systematic literature review of studies investigating OSA and cirrhosis.
- Analysis of current data on the prevalence and impact of OSA in liver disease patients.
- Evaluation of the potential benefits of continuous positive airway pressure (CPAP) therapy.
Main Results:
- Individuals with OSA show a higher prevalence of liver disease.
- Continuous positive airway pressure (CPAP) treatment may mitigate the advancement of liver disease.
- Screening for sleep disturbances is recommended for patients with liver disease and a BMI over 30.
Conclusions:
- OSA is associated with an increased likelihood of cirrhosis.
- Early identification and management of OSA are crucial for improving outcomes in patients with liver disease.
- Addressing sleep disturbances can enhance patient well-being and liver disease management.
Keywords:
cirrhosiscontinuous positive airway pressure (CPAP)liver injuryobstructive sleep apnea (OSA)More Related Videos
Related Concept Videos
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:21Sleep Apnea
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...